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LETTERS TO THE EDITOR
Sick Sinus Syndrome
Gillette's discussion of the sick sinus syndrome (I) is marred by
several unsubstantiated statements and one flagrant misquotation.
The tragic implications of needless pacemaker implantation in
children make it imperative that the facts at issue be stated clearly
and accurately.
I. The author states, "Instances of sick sinus syndrome in
children who did not have congenital heart disease or cardiac
surgery have been reported. At least one death in this group has
been noted (2)." In fact, the case cited was that of a child born
with transposition of the great arteries: the infant was cyanotic and
seriously distressed at birth. A septostomy was performed, but the
child died of aspiration of a nasogastric feed at the age of I week.
How Gillette concluded that this child fell in the group "without
congenital heart disease" is a mystery. The child suffered from
intractable tachyarrhythmias during its week of life: no brady-
arrhythmias were ever recorded. At postmortem there was evidence
of hypoplasia and fibrosis of the sinus node: the authors speculated
that absence of adequate sinus node function might possibly have
played a role in the genesis of the tachyarrhythmias, but admitted
this was only conjecture. In fact, there are no documented cases
of death in children-or, for that matter, in adults-caused by the
sick sinus syndrome, as such, in an otherwise healthy heart. We
have conducted two computer-assisted reviews of the world med-
ical literature and can find no exceptions to this observation. The
excellent review of Shaw et al. (3) is worthy of study in this
context.
2. Type I block is a normal response of the AV node to pacing;
the rate at which such block appears varies widely from individual
to individual and even from hour to hour in the same individual.
It can usually be modified drastically or eliminated by atropine.
No data have ever been published correlating the rate at which
type I block appears during atrial pacing with the subsequent
development of AV node disease or dysfunction. In fact, no such
data exist. Josephson (4) noted that the various rates at which type
I periods appeared in normal persons form a bell-shaped curve,
beginning in the lower 70s peaking at about 130 to 140 beats/min,
and falling off sharply at about 180 beats/min. He further points
out that the wide range of paced cycle lengths at which type I
block appears are a manifestation of differences in the basal state
of the patients at the time of the study: he notes that occasional
healthy young adults develop type I block at a relatively slow rate
as a consequence of enhanced vagal tone. In a previous article,
Beder et al. (5) claimed that "the atrial cycle pacing length at
which AV nodal Wenckebach periods occurred was a particularly
sensitive indicator of atrioventricular node abnormality," but cited
no data to support this view: it would be more accurate to say that
the specificity of this measurement is substantially nonexistent.
Because this misapprehension has emerged elsewhere it is worth
expunging definitively at this time. Practically all normal individ-
uals will manifest some type of AV node block in response to
atrial pacing. The pacing rate at which the block appears and the
form it takes will vary with a number of factors including the
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manner in which the pacing rate is increased, and the level of
sympathetic discharge. It may be assumed that patients with overt
AV node disease will manifest an exaggerated response to atrial
pacing with block appearing at lower rates, or higher degrees of
block. The overlap between the two subsets, however, is enor-
mous, and has never been precisely studied for the very good
reason that, for all reasonable clinical purposes, assessment of AV
node function is accomplished by a knowledgeable inspection of
the electrocardiogram recorded at various rates. Once overt AV
node block has appeared, it can be characterized with remarkable
precision by analysis of the surface electrocardiogram: the response
of the AV node to atrial pacing adds no useful information. To
tell a patient with normal AV conduction during adequate electro-
cardiographic study that future or impending AV node block could
be predicted on the basis of the rate at which type I block was
elicited during pacing would be to make a statement for which
there is no foundation in scientific fact. The same is true of attempts
to decide mode and site of pacing on the basis of this insignificant
measurement.
3. Finally, Gillette makes the blanket statement that" Inpatients
with syncope, if the heart rate decreases to less than 50 beats/min
in an infant, 40 beats/min in a toddler or 30 beats/min in a teenager,
it may be assumed that bradycardia is the cause of the symptoms."
He bases these generalities on a series of eight cases, which means
there could have been only two, or at most three, in each category
(5). Two cases are an anecdote, not a statistic. In addition, with
pacemaker insertion looming, it is hazardous to make such state-
ments as these without qualifications and guidelines. Is the brady-
cardia transient or sustained? If the bradycardia is episodic, how
long is it maintained? Does it appear only during sleep or does it
persist in the face of physical activity? Have transient reversible
causes of bradycardia been excluded before it is concluded that
the condition warrants definitive treatment?
The almost miraculous evolution of pacemaker technology has
brought in its wake a need for precise definition of the types of
abnormality of impulse generation and conduction and their sig-
nificance. The established criteria for valid scientific investigation
will protect both the clinician and the patient from the conse-
quences of overdiagnosis, unwarranted prognostication and med-
dlesome invasion: they should be followed scrupulously.
BRENDAN PHIBBS, MD, FACC
Section of Cardiology
University of Arizona Medical Center
Tucson, Arizona 85721
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Reply
I must disagree with Phibbs' statements in the strongest possible
way . There are no flagrant misquotations in our article. We did
make a mistake in Reference I . We intended to refer to the work
of Van der Hauwaert and Ector (I) rather than to the article by
Fox et al. We must have inadvertently transposed reference s when
preparing the manuscript.
Phibbs ' computer-assisted reviews must be faulty because there
are at least two other articles that describe children who died after
having documented sick sinus syndrome. One is by James et al.
(2) and the other is by Bharati et al. (3). The patient of Bharati
et al. had a ventric ular septal defect in infancy that closed spon-
taneously, and death did not occur until the child was 16 years of
age. I have concluded that that patient did not have significant
congenital heart disease anywhere near the time of death . These
last two articles also give histopathologic correl ation to the electro-
cardiographic and electrophysiologic findings and indicate that
there is pathologic basis for sinus node dysfunction .
Phibbs does not seem to understand how we are using the
response to atrial pacing. Probably everyone knows that it is normal
for a patient to develo p type I block during atrial pacing , and we
certainly do . In pediatric patients who are sedated with Demerol
and Phenergan before study, the pacing rate at which type I block
occurs is higher. Normal values have been clearly developed and
are published in our book (4). I agree that it is very difficult to
predict future onset of atrioventricular (AV) block using this test;
however, we have been very successful in predicting nononset of
AV block using a rate greater than 120 beats/min . We feel that
the AV node will contin ue to conduct normally for some length
of time, probably at least 10 years, and we find it useful to insert
an atrial pacemaker. If second degree block develops at a lesser
rate while the patien t is sedated with Demerol and Phenergan , we
feel there is a possibility that AV block might develo p at a later
Correction
Table I on page 532 of the September issue of the Journal was
printed incorrectly (Blaustein AS , Risser TA , Weiss JW, Parker
Table 1. Basel ine Hemodynamic Variables
time and therefore we use a dual chamber pacemaker. We have
not subjected this idea to random study because we feel that it
might be dangerous to the patient to do so . We also feel that the
difference between a dual and a single chamber pacemaker is not
too great in cost or trauma to the patient and therefore prefer to
use a dual chamber pacemaker if there is any question of AV
conduction .
I think if Phibbs had thought his third point out carefull y he
would agree that the heart rates described are very conservative .
These rates are intended for patien ts who are awake and they
occurred for 6 seconds. When one is dealing with patients, one
has to develop some criteria for action . I have developed these
criteria over a long period of time working with pediatric patients.
I have no concern that these rates are too high; I have some concern
that they may be too low. When one is dealing with patients after
the Mustard operation for example , in whom many centers have
found a 5% or greater incidence of sudden death, it is important
to establish criteria for pacemaker implantation to try to prevent
such sudden death . I do not think that we can afford to wait until
we have abso lute statistical evidence that our criteria are exactly
right before we can begin to use our common sense .
The main point of my article was that most causes of sudden
death in children are now treatable and thus preventable. If we
take Phibbs' point of view , we will not prevent many of these
sudden deaths .
PAUL C. GILLETTE, MD, FACC
South Carolina Children's Heart Center
Medical University of South Carolina
171 Ashley Avenue
Charleston. South Carolina 29425
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The following is the correct version of the table :
Esophageal
Pressure
Heart Blood Pulsus (mmHg) LVEF(%) RVEF(%)
Rate Pressure Paradoxus
Case (min- I) (mm Hg) (mm Hg) E E E
I 75 129/88 I -4 0 73 72 41 50
2 70 96/57 4 -5 -I 71 63 39 36
3 80 128/81 7 -1 2 -4 69 73 54 37
4 61 117/68 6 -4 0 85 85 40 38
5 76 144/97 6 -5 -I 85 95 31 32
6 81 150/103 3 -3 +2 71 66 37 36
Mean 73.8 127/82 4.5 - 5.5 -0.7 76 76 40.3 38.2
+SEM 3.3 8.517.6 1.0 1.5 0.9 3.2 4.9 3.4 2.8
E = expiration; EF = radionuclide ejection fraction; 1 = inspiration; LV = left ventricle; RV = right ventricle.
